secwatch / observer
8-K filed May 27, 2026, 5:00 PM ET ticker ELAN CIK 0001739104
other confidence high sentiment neutral materiality 0.15

Elanco shareholders elect all director nominees, ratify EY, approve say-on-pay at annual meeting

Elanco Animal Health Inc

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Elanco Animal Health Inc shareholders approved Non-binding approval of compensation of named executive officers at the 2026-05-21 meeting.

Proposal
say on pay
Outcome
passed
Meeting
2026-05-21
Exact text from the filing
Proposal 3. The shareholders approved, by non-binding vote, the compensation of Elanco’s named executive officers, by the votes set forth in the table below.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Elanco Animal Health Inc shareholders approved Election of Directors at the 2026-05-21 meeting.

Proposal
director election
Outcome
passed
Meeting
2026-05-21
Exact text from the filing
Elanco Animal Health Incorporated (the “Company”) held its annual meeting of shareholders on May 21, 2026. Voting results for each matter submitted to a vote at the 2026 annual meeting are provided below. Proposal 1. Election of Directors.
View on SEC.gov
Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Elanco Animal Health Inc shareholders approved Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026 at the 2026-05-21 meeting.

Proposal
auditor ratification
Outcome
passed
Meeting
2026-05-21
Exact text from the filing
Proposal 2. The shareholders ratified the appointment of Ernst & Young LLP as Elanco’s independent registered public accounting firm for 2026, by the votes set forth in the table below.
View on SEC.gov

Browse all shareholder votes →

Elanco Animal Health Inc filing history →

Source: SEC EDGAR
accession 0001104659-26-067002
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.